Advanced Fertility Center of Chicago, S.C.

Advanced Fertility Center of Chicago (AFCC) is a leading provider of fertility treatments, offering personalized solutions including IVF, IUI, and genetic testing to support individuals and couples on their path to parenthood. Founded in 1997 in Chicago, US, Advanced Fertility Center of Chicago provides specialized fertility services. The company was acquired by Prelude Fertility, Inc. in March 2018 as part of an expansion strategy.

Its founder has a background in fertility medicine and has been instrumental in establishing the clinic's reputation in the sector. Advanced Fertility Center of Chicago specializes in comprehensive fertility treatment and care, focusing on personalized solutions to assist individuals and couples in their journey toward parenthood. Core offerings include in vitro fertilization (IVF), intrauterine insemination (IUI), egg freezing, and genetic testing services such as preimplantation genetic testing (PGT). The clinic employs advanced reproductive technologies and a supportive financial model to cater to a diverse clientele, including individuals seeking fertility support, LGBTQ+ families, and those experiencing recurrent miscarriages or advanced maternal age challenges.

Established in 1997, AFCC serves patients primarily across Illinois, with additional outreach to neighboring states and clients from Canada, ensuring access to cutting-edge reproductive healthcare. AFCC generates revenue through a direct-to-consumer model, where patients engage in consultations and treatment plans tailored to their specific fertility needs. The financial structure of services typically involves one-time fees for procedures such as IVF, which includes multiple stages like egg retrieval, embryo transfer, and monitoring. Patients may also incur costs associated with genetic testing and fertility preservation, such as egg freezing.

AFCC's pricing structure is designed to align with the comprehensive nature of its services, which are delivered by a team of award-winning fertility specialists. The clinic emphasizes transparent pricing and financing options to assist patients in managing the costs associated with fertility treatments, reflecting its commitment to accessibility and patient-centered care. Following its acquisition by Prelude Fertility, Inc. in March 2018, AFCC plans to leverage its resources for future growth.

The company is focusing on expanding its service offerings, particularly in genetic testing and fertility preservation, with new product launches anticipated in the next 12 to 24 months. Additionally, AFCC aims to broaden its market reach beyond Illinois, targeting nearby states and Canada for enhanced patient access. Funding from the recent acquisition will support these initiatives, facilitating the clinic's strategic expansion into new markets.